Abrégé

The present invention relates to a method for producing a raw material for a fertilizer, the method being characterized by subjecting glass to ion exchange using a molten salt containing potassium nitrate, cooling and solidifying the molten salt, and obtaining a salt containing potassium nitrate. The present invention also relates to a raw material for a fertilizer, which comprises a plurality of blocks. The raw material for a fertilizer is characterized in that: the proportion of water-soluble potassium is 40 wt% or more relative to the raw material for a fertilizer; the proportion of nitrate nitrogen is 11 wt% or more relative to the total amount of the raw material for a fertilizer; and when two blocks, each having a mass of 50-150 g, are sampled per 10 kg of the raw material for a fertilizer, the difference in the concentration of water-soluble potassium between the two blocks is 6.0 wt% or less and the difference in the concentration of nitrate nitrogen between the two blocks is 1.9 wt% or less.

Classes IPC  ?

• C05C 5/02 - Engrais contenant d'autres nitrates contenant du nitrate de sodium ou de potassium
• C03C 21/00 - Traitement du verre, autre que sous forme de fibres ou de filaments, par diffusion d'ions ou de métaux en surface

Abrégé

[Problem] To provide: paramylon-cellulose mixed fibers having improved water resistance; a nonwoven fabric produced by using the mixed fibers; and a sanitary mask produced by using the nonwoven fabric. [Solution] The present invention solves the problem by providing paramylon-cellulose mixed fibers in which the mass ratio of paramylon to cellulose is set to be in the range of 70:30 to 50:50. In addition, the present invention solves the problem by providing a method for producing paramylon-cellulose mixed fibers, the method including: a spinning dope preparation step for dissolving and mixing cellulose and paramylon in an ionic solution; and a spinning step for discharging the spinning dope obtained in the spinning dope preparation step to a coagulation liquid to form a yarn by a dry-wet spinning method, wherein the sum of the cellulose and the paramylon is 10-30 mass% of the ionic solution, and the mass ratio of the paramylon to the cellulose is in the range of 70:30 to 50:50.

Classes IPC  ?

• D01F 2/00 - Filaments, ou similaires, artificiels, à un seul composant, formés de cellulose ou de dérivés de la celluloseLeur fabrication
• A41D 13/11 - Masques de protection du visage, p. ex. pour utilisation chirurgicale ou pour utilisation en atmosphère polluée
• D01D 5/06 - Méthodes de filage au mouillé
• D04H 1/492 - Non-tissés formés uniquement ou principalement de fibres coupées ou autres fibres similaires relativement courtes à partir de voiles ou couches composés de fibres ne possédant pas des propriétés cohésives réelles ou potentielles les voiles ou couches étant renforcées par des moyens mécaniques, p. ex. par roulage par aiguilletage ou opérations similaires pour provoquer l'enchevêtrement des fibres par jet de fluide
• D04H 1/4258 - Famille des celluloses régénérées
• D04H 1/4382 - Fibres obtenues par étirage de film réticuléFibres compositesFibres mixtesFibres ultrafinesFibres pour cuir artificiel

Abrégé

The present invention provides a method for extracting a fatty acid from Euglena oil which contains a wax ester having a group derived from an alcohol having 8-18 carbon atoms, said method comprising: a step for adding an alkaline solution containing ethanol to Euglena oil and saponifying and decomposing a wax ester into fatty acid soap and an alcohol having 8-18 carbon atoms; a step for adding water and oil/fat for extraction and separating and removing the alcohol having 8-18 carbon atoms; a step for adding an acid and decomposing the fatty acid soap into a fatty acid and a salt; and a step for adding one or two selected from the group consisting of water and hexane as an extraction solvent and separating and recovering the fatty acid from an ethanol/water layer, wherein the oil/fat for extraction contains a triglyceride containing a fatty acid residue having 13 or more carbon atoms in an amount of not less than 60 mass%.

Classes IPC  ?

• C11B 1/10 - Production des graisses ou huiles à partir de matières premières par extraction
• C11B 7/00 - Séparation des mélanges de graisses ou huiles en leurs constituants, p. ex. séparation des huiles saturées des huiles non saturées

Abrégé

The prevent invention provides a food composition for preventing a disorder due to atmospheric pollution and an agent for preventing a disorder due to atmospheric pollution.　Provided are a food composition and an agent which are for preventing a disorder due to atmospheric pollution and which comprise an extract of watermelon. The disorder is preferably a lung disorder. The watermelon is preferably a wild watermelon. The extract is preferably juice obtained from a watermelon fruit.

Classes IPC  ?

• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
• A61K 36/42 - Cucurbitaceae (famille du concombre)
• A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]

Abrégé

Provided is a novel aqueous composition with which the effects of effective components of paramylon can be exhibited.　This aqueous composition contains at least a paramylon fiber (A) and water (B), wherein the paramylon fiber (A) satisfies the following requirements (a) and (b). (a) The paramylon fiber has an anionic functional group. (b) The total content of aldehyde groups and ketone groups is at most 0.5 mmol/g per dry mass of the paramylon fiber. An aqueous composition according to the present invention has favorable stability over time and thermal stability, can suppress yellowing even when left alone for one week, and has favorable physical properties with no decrease in viscosity.

Classes IPC  ?

• A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61K 8/73 - Polysaccharides
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
• A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
• A61Q 19/00 - Préparations pour les soins de la peau
• A61Q 19/08 - Préparations contre le vieillissement

Abrégé

Provided is an oral composition for preventing and/or improving cold symptoms.　This oral composition for preventing and/or improving cold symptoms contains euglena algae. It is preferable for the cold symptoms in this case to be one or more symptoms selected from the group consisting of general malaise, chills, feverishness, fatigue, sneezing, nasal discharge, nasal congestion, sore throat, coughing, joint pain, myalgia and headache. It is preferable for the oral consumption to be a food product, a beverage or a medicine.

Classes IPC  ?

• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61K 35/748 - Cyanobactéries, c.-à-d. bactéries bleu-vert ou algues bleu-vert, p. ex. spiruline
• A61P 11/02 - Agents rhinologiques, p. ex. décongestionnants
• A61P 11/04 - Médicaments pour le traitement des troubles du système respiratoire des maux de gorge
• A61P 11/14 - Antitussifs
• A61P 19/02 - Médicaments pour le traitement des troubles du squelette des troubles articulaires, p. ex. arthrites, arthroses
• A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]

Abrégé

The present invention provides a cosmetic composition, a cosmetic composition for epidermal keratinocyte proliferation, an epidermal keratinocyte proliferation agent, an antioxidant, a cosmetic composition for dermal papilla cell proliferation, a dermal papilla cell proliferation agent, and a hair restorer.　The problem is solved by a cosmetic composition, a cosmetic composition for epidermal keratinocyte proliferation, an epidermal keratinocyte proliferation agent, an antioxidant, a cosmetic composition for dermal papilla cell proliferation, a dermal papilla cell proliferation agent, and a hair restorer containing a Euglena-derived substance and an animal cell-derived culture supernatant. The Euglena-derived substance may be a Euglena aqueous solvent extract or a water-soluble component extracted upon performing protein enzymatic decomposition of cells of algae belonging to the genus Euglena. The culture supernatant may be a culture supernatant of an embryonic membrane derived from a fertilized bird egg, or specifically a supernatant of a chicken extraembryonic membrane cell conditioned medium.

Classes IPC  ?

• A61K 8/9706 - Algues
• A61K 8/98 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés d'origine animale
• A61K 35/57 - OiseauxSubstances provenant des oiseaux, p. ex. œufs, plumes, blanc d’œuf, jaune d’œuf ou endothelium corneum gigeriae galli
• A61K 35/68 - Protozoaires, p. ex. flagelles, amibes, sporozoaires, plasmodium ou toxoplasma
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
• A61P 17/18 - Antioxydants, p. ex. antiradicaux
• A61P 39/06 - Antiradicaux libres ou antioxydants
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
• A61Q 19/00 - Préparations pour les soins de la peau
• C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains

Abrégé

Provided is a food composition containing a tempeh fermentation product of microalgae, a cosmetic composition, and a pharmaceutical composition.　The present invention makes it possible to obtain a tempeh fermentation product of microalgae by a method characterized by performing: a step for steaming soybeans, mixing microalgae algal body and tempeh, and preparing a mixture of the microalgae algal body and the tempeh; a mixing step for obtaining a tempeh fermentation product raw material by adding the mixture of the microalgae algal body and the tempeh obtained in the aforementioned step to the steamed soybeans; and a fermentation step for fermenting the tempeh fermentation product raw material.

Classes IPC  ?

• C12N 1/14 - ChampignonsLeurs milieux de culture
• A23L 11/50 - Légumes secs ou légumineuses fermentésFermentation de légumes secs ou de légumineuses par l’entremise de micro-organismes ajoutés
• A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
• A61K 8/9722 - Chlorophycota ou Chlorophyta [algues vertes], p. ex. Chlorella
• A61K 8/9728 - Champignons, p. ex. levures
• A61K 8/9789 - Magnoliopsida [dicotylédones]
• A61K 36/05 - Chlorophycota ou chlorophyta (algues vertes), p. ex. Chlorella
• A61K 36/062 - Ascomycota
• A61K 36/48 - Fabaceae ou Leguminosae (famille du pois ou des légumineuses)CaesalpiniaceaeMimosaceaePapilionaceae
• C12N 1/12 - Algues unicellulairesLeurs milieux de culture

Abrégé

The present invention provides a food composition, a dried material and a powderization method.　Provided is a dried material or a food composition containing Labyrinthulomycetes, dextrin, and/or tocopherol. Also provided is a powderization method in which drying is performed after dextrin and/or tocopherol is added prior to drying cultured Labyrinthulomycetes, wherein it is suitable to perform the drying with use of a disk dryer or a jet drier.

Classes IPC  ?

• A23L 5/00 - Préparation ou traitement des aliments ou produits alimentaires en généralAliments ou produits alimentaires ainsi obtenusLeurs matériaux
• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
• A23L 33/15 - Vitamines

Abrégé

The present invention pertains to a new method that is for utilizing euglena and that allows ingestion of rich nutrients in euglena by a simple method. The present invention provides a seafood flavor enhancer that is for a food product containing seafood as a raw material, and that contains a euglena-derived substance as an active ingredient. According to the present invention, a highly palatable food product having enhanced seafood flavor can be provided by adding the seafood flavor enhancer to a food product containing seafood as a raw material. According to the present invention, euglena can be easily incorporated into daily meals, and rich nutrients in euglena can be ingested by a simple method.

Classes IPC  ?

• A23L 27/10 - Épices, agents aromatiques ou condiments naturelsLeurs extraits
• A23L 17/00 - Produits tirés de la merProduits à base de poissonFarine de poissonSuccédanés d’œufs de poissonLeur préparation ou leur traitement
• A23L 17/60 - Algues comestibles
• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés

Abrégé

Provided are a crop freshness retention improvement agent containing Euglena, a fertilizer composition for crop freshness retention improvement, and a method for improving crop freshness retention using Euglena.　A crop freshness retention improvement agent, and a fertilizer composition for crop freshness retention improvement, characterized by containing Euglena as an active ingredient, and being used for retaining the freshness of a crop; and a method for improving crop freshness retention characterized by performing a step for adding Euglena to soil, and causing retention of the freshness of a crop.

Classes IPC  ?

• A01G 22/15 - Légumes-feuilles, p. ex. laitue ou épinards
• A01G 24/22 - Substrats de cultureMilieux de cultureAppareils ou méthodes à cet effet basés sur ou contenant de la matière organique naturelle contenant de la matière végétale
• C05F 11/08 - Engrais organiques comportant l'addition de cultures bactériennes, de mycélium ou similaires

Abrégé

The present invention provides a GLS1 gene-inhibiting cosmetic material composition, a GLS1 gene inhibitor, a cosmetic material composition for senescent cell removal, and a senescent cell removing agent.　The problem addressed by the present invention is solved by a GLS1 gene-inhibiting cosmetic material composition and a GLS1 gene inhibitor that are characterized by containing a Euglena-derived substance as an active ingredient, being used to inhibit the expression of the GLS1 gene in the skin, and being transdermally applied, the Euglena-derived substance being a Euglena aqueous solvent extract or a water-soluble component extracted by protein enzymolysis of cells of algae belonging to the genus Euglena.　The problem addressed by the present invention is also solved by a cosmetic material composition for senescent cell removal and a senescent cell removing agent that are characterized by containing a Euglena-derived substance as an active ingredient, being used to remove senescent cells of the skin, and being transdermally applied, the Euglena-derived substance being a Euglena aqueous solvent extract or a water-soluble component extracted by protein enzymolysis of cells of algae belonging to the genus Euglena.

Classes IPC  ?

• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
• A61Q 19/08 - Préparations contre le vieillissement
• A61K 36/02 - Algues
• A61K 36/05 - Chlorophycota ou chlorophyta (algues vertes), p. ex. Chlorella
• A61K 8/97 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base d’algues, de champignons, de lichens ou de plantesCosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de leurs dérivés
• A61K 8/9706 - Algues

Produits et services

Breath freshening preparations for personal hygiene; deodorants for pets; soaps and detergents; facial washes; shampoos; hair conditioners; dentifrices; cosmetics; toilet water; beauty masks; milk for cosmetic purposes; cosmetic creams; hair care preparations; hand creams; perfume and flavour materials; incense; bath preparations, not for medical purposes; aromatic oils for the bath; cleaning preparations for personal sanitary purposes; detergents for household use. Pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; immunostimulants; sanitizing preparations for household use; sanitary preparations for personal hygiene, other than toiletries; medicated toiletry preparations; bath preparations for medical purposes; reagent paper for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages for medical purposes; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; cotton wool for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages; breast-nursing pads; cotton swabs for medical purposes; diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals. Soft drinks; fruit juices; vegetable juices [beverages]; whey beverages.

Produits et services

Breath freshening preparations for personal hygiene; deodorants for pets; soaps and detergents; facial washes; shampoos; hair conditioners; dentifrices; cosmetics; toilet water; beauty masks; milk for cosmetic purposes; cosmetic creams; hair care preparations; hand creams; perfume and flavour materials; incense; bath preparations, not for medical purposes; aromatic oils for the bath; cleaning preparations for personal sanitary purposes; detergents for household use. Pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; immunostimulants; sanitizing preparations for household use; sanitary preparations for personal hygiene, other than toiletries; medicated toiletry preparations; bath preparations for medical purposes; reagent paper for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages for medical purposes; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; cotton wool for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages; breast-nursing pads; cotton swabs for medical purposes; diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals. Soft drinks; fruit juices; vegetable juices [beverages]; whey beverages.

Produits et services

Breath freshening preparations; deodorants for animals; soaps and detergents; facial washes; shampoos; hair conditioners; dentifrices; cosmetics; toilet water; cosmetic creams; hair care preparations; hand creams; perfumes and essential oils; incense; bath preparations, not for medical purposes; aromatic oils for the bath.

Abrégé

Provided are a food composition for modulating CLOCK gene expression, a cosmetic composition for modulating CLOCK gene expression, a CLOCK gene expression modulator, a food composition for in-vivo CLOCK modulation, a cosmetic composition for in-vivo CLOCK modulation, an in-vivo CLOCK modulator, a food composition for modulating circadian rhythm, a cosmetic composition for modulating circadian rhythm, and a circadian rhythm modulator.　The problem addressed by the present invention is solved by a food composition for modulating CLOCK gene expression, a cosmetic composition for modulating CLOCK gene expression, a CLOCK gene expression modulator, a food composition for in-vivo CLOCK modulation, a cosmetic composition for in-vivo CLOCK modulation, an in-vivo CLOCK modulator, a food composition for modulating circadian rhythm, a cosmetic composition for modulating circadian rhythm, and a circadian rhythm modulator that are characterized by containing, as an active ingredient, at least one Euglena-derived substance selected from the group consisting of paramylon and Euglena.

Classes IPC  ?

• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
• A61Q 1/00 - Préparations pour le maquillagePoudres corporellesPréparations pour le démaquillage
• A61Q 19/00 - Préparations pour les soins de la peau
• A61K 36/02 - Algues
• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61K 8/73 - Polysaccharides
• A61K 8/97 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base d’algues, de champignons, de lichens ou de plantesCosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de leurs dérivés
• A61K 8/99 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de micro-organismes autres que des algues ou des champignons, p. ex. à base de protozoaires ou de bactéries
• A61K 35/68 - Protozoaires, p. ex. flagelles, amibes, sporozoaires, plasmodium ou toxoplasma
• A61K 31/716 - Glucanes

Produits et services

Breath freshening preparations for personal hygiene; deodorants for pets; non-medicated soaps; detergent soap; facial washes; shampoos; hair conditioners; dentifrices; cosmetics; toilet water; beauty masks; milk for cosmetic purposes; cosmetic creams; hair care preparations; hand creams; perfume and flavour materials, namely, essential oils; incense; bath preparations, not for medical purposes; aromatic oils for the bath; cleaning preparations for personal sanitary purposes; detergents for household use; all of the foregoing goods containing Euglena flagellates Preparations for destroying vermin, fungicides, herbicides; Pharmaceutical preparations for the treatment of immune system health, sleep disfunction, mood enhancement, and gastrointestinal diseases and conditions; immunostimulants; sanitizing preparations for household use; sanitary preparations for personal hygiene for medical use, other than toiletries; medicated toiletry preparations; bath preparations for medical purposes; reagent paper for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; capsules sold empty for pharmaceuticals; eyepatches for medical purposes; ear bandages for medical purposes; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; cotton wool for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical purposes; infant diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dairy based beverages for babies; food for babies; dietary supplements for animals; all of the foregoing goods containing Euglena flagellates Soft drinks; fruit juices; beverages, namely, vegetable juices; whey beverages; all of the foregoing goods containing Euglena flagellates

Abrégé

Provided are: a compost fermentation promoting agent that contains euglena; a method for producing compost using euglena; a method for fermenting compost; a compost material; a compost fermentation product; and a culture soil.　This compost fermentation promoting agent contains euglena that has been subjected to a drying process and/or a mechanical process. This method for producing compost comprises adding euglena that has been subjected to a drying process and/or a mechanical process to a compost raw material and fermenting same. This method for fomenting compost comprises adding euglena that has been subjected to a drying process and/or a mechanical process to a compost raw material and fermenting same. This compost material contains a compost raw material and euglena that has been subjected to a drying process and/or a mechanical process. This compost fermentation product contains a compost raw material and euglena that has been subjected to a drying process and/or a mechanical process. This culture soil contains the compost fermentation product that contains a compost raw material and euglena that has been subjected to a drying process and/or a mechanical process.

Classes IPC  ?

• C05F 17/20 - Emploi de microorganismes ou de substances, p. ex. d'enzymes, pour activer ou stimuler le traitement
• B09B 3/00 - Destruction de déchets solides ou transformation de déchets solides en quelque chose d'utile ou d'inoffensif
• C02F 11/02 - Traitement biologique
• C05F 3/00 - Engrais fabriqués à partir des excréments humains ou animaux, y compris le fumier
• C05F 11/08 - Engrais organiques comportant l'addition de cultures bactériennes, de mycélium ou similaires
• C12N 1/12 - Algues unicellulairesLeurs milieux de culture

Abrégé

Provided are an agent for suppressing the increment of a blood glucose level, a diabetes preventing agent and a food composition, which are novel uses of a carotenoid mixture derived from a microalga. An agent for suppressing the increment of a blood glucose level, a diabetes preventing agent and a food composition, each of which contains a carotenoid mixture derived from a microalga as an active ingredient, wherein the carotenoid mixture contains diatoxanthin as the main component thereof. The carotenoid mixture derived from a microalga is, for example, a carotenoid mixture derived from euglena, which contains diatoxanthin as the main component thereof, and also contains zeaxanthin and alloxanthin. The agent can be used for suppressing the increment of a blood glucose level through the ingestion together with, for example, a high-GI food.

Classes IPC  ?

• A61K 35/68 - Protozoaires, p. ex. flagelles, amibes, sporozoaires, plasmodium ou toxoplasma
• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
• A61P 3/10 - Médicaments pour le traitement des troubles du métabolisme de l'homéostase du glucose de l'hyperglycémie, p. ex. antidiabétiques

Abrégé

Provided are: a method for producing a hydrocarbon whereby the hydrocarbon can be efficiently produced using a biomass while minimizing a loss in a carbon source; and a method for producing a biocrude. A method for producing a biocrude, said method comprising: a mixing step for mixing a biomass with a solvent containing an oxygen-containing aromatic compound to give a mixture; and a solvolysis step for heating the mixture to 190-250°C to thereby solvolyze the mixture.

Classes IPC  ?

• C10G 1/00 - Production de mélanges liquides d'hydrocarbures à partir de schiste bitumineux, de sable pétrolifère ou de matières carbonées solides non fusibles ou similaires, p. ex. bois, charbon
• C10G 3/00 - Production de mélanges liquides d'hydrocarbures à partir de matières organiques contenant de l'oxygène, p. ex. huiles, acides gras
• C10G 11/05 - Alumino-silicates cristallins, p. ex. tamis moléculaires
• C10G 11/18 - Craquage catalytique, en l'absence d'hydrogène, des huiles d'hydrocarbures avec catalyseurs solides mobiles préchauffés selon la technique du "lit fluidisé"

Abrégé

Provided are: an acyl novel steryl glucoside; and a method for producing an acyl steryl glucoside by using labyrinthula as a raw material. This acyl steryl glucoside is represented by structural formula (I), structural formula (II), or structural formula (III).

Classes IPC  ?

• C12P 19/56 - Préparation d'O-glucosides, p. ex. glucosides avec un atome d'oxygène du radical saccharide lié directement à un système cyclique condensé d'au moins trois carbocycles, p. ex. daunomycine, adriamycine
• A23L 31/00 - Extraits ou préparations comestibles de champignonsLeur préparation ou leur traitement
• A61K 8/99 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de micro-organismes autres que des algues ou des champignons, p. ex. à base de protozoaires ou de bactéries
• A61K 31/704 - Composés ayant des radicaux saccharide liés à des composés non-saccharide par des liaisons glycosidiques liés à un composé carbocyclique, p. ex. phloridzine liés à un système carbocyclique condensé, p. ex. sennosides, thiocolchicosides, escine, daunorubicine, digitoxine
• A61K 35/74 - Bactéries
• A61P 3/04 - AnorexigènesMédicaments de l'obésité
• A61P 3/06 - Antihyperlipémiants
• A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale
• A61P 17/14 - Médicaments pour le traitement des troubles dermatologiques pour le traitement de la calvitie ou de l'alopécie
• A61P 35/00 - Agents anticancéreux
• A61P 39/06 - Antiradicaux libres ou antioxydants
• A61Q 19/00 - Préparations pour les soins de la peau
• A61Q 19/06 - Préparations pour lutter contre la cellulite
• C07J 9/00 - Stéroïdes normaux contenant du carbone, de l'hydrogène, un halogène ou de l'oxygène, substitués en position 17bèta par une chaîne de plus de deux atomes de carbone, p. ex. cholane, cholestane, coprostane
• C07J 13/00 - Stéroïdes normaux contenant du carbone, de l'hydrogène, un halogène, ou de l'oxygène, ayant une double liaison carbone-carbone à partir de ou vers la position 17
• C12N 1/14 - ChampignonsLeurs milieux de culture
• C12P 7/62 - Esters d’acides carboxyliques
• C12P 19/44 - Préparation d'O-glucosides, p. ex. glucosides

Abrégé

The present invention provides a food composition for increasing muscle mass, muscle mass increasing agent, therapeutic agent for locomotive syndrome, therapeutic agent for sarcopenia, exercise function maintenance agent, muscle atrophy-related gene expression inhibitor, muscle protein degradation inhibitor, muscle atrophy prevention agent, muscle synthesis-related gene expression promoter, and muscle synthesis promoter. A food composition for increasing muscle mass, muscle mass increasing agent, therapeutic agent for locomotive syndrome, therapeutic agent for sarcopenia, exercise function maintenance agent, muscle atrophy-related gene expression inhibitor, muscle protein degradation inhibitor, muscle atrophy prevention agent, muscle synthesis-related gene expression promoter, and muscle synthesis promoter, characterized in containing a Euglena-derived substance as an active ingredient.

Classes IPC  ?

• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61K 36/02 - Algues
• A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire

Abrégé

Provided is a method for evaluating the freshness (redox degree) or the like of a substance being tested such as an agricultural crop, on the basis of analysis results of a plurality of sulfur compounds and a plurality of sulfur metabolism related compounds. Also provided is a method for quantifying a volatile low molecular weight sulfur compound by liquid chromatography mass spectrometry. This method for evaluating a sulfur compound-containing substance by evaluating a plurality of substances being tested for is characterized by comprising: a step of preparing, for each substance being tested for, a quantitative value of a plurality of sulfur compounds and a plurality of sulfur metabolism related compounds; a step of analyzing analysis values of the substance being tested for, including the quantitative value, by multidimensional scaling, to create a scatter diagram having at least two types of scale selected from the group comprising a redox degree, a microbial metabolism contribution, an antioxidant capacity, or an odor or bad odor; and a step of evaluating the redox degree, the microbial metabolism contribution, the antioxidant capacity, or the odor or bad odor of the substance being tested for, on the basis of the position on the scatter diagram.

Classes IPC  ?

• G01N 30/06 - Préparation
• G01N 27/62 - Recherche ou analyse des matériaux par l'emploi de moyens électriques, électrochimiques ou magnétiques en recherchant l'ionisation des gaz, p. ex. des aérosolsRecherche ou analyse des matériaux par l'emploi de moyens électriques, électrochimiques ou magnétiques en recherchant les décharges électriques, p. ex. l'émission cathodique
• G01N 30/72 - Spectromètres de masse
• G01N 30/88 - Systèmes intégrés d'analyse, spécialement adaptés à cet effet, non couverts par un seul des groupes
• G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique

Abrégé

Provided are a euglena koji‐mold fermentation product, a euglena koji‐mold fermentation product raw material, and a method for producing the euglena koji‐mold fermentation product. The present invention makes it possible to obtain a euglena koji‐mold fermentation product raw material by a method characterized by performing: a step for steaming grains and mixing a euglena algal component and koji‐mold to prepare a mixture of the euglena algal component and koji mold; a mixing step for obtaining a koji‐mold fermentation product raw material by coating the steamed grains with the mixture of the euglena algal component and koji mold obtained in the previous step; and a fermentation step for fermenting the koji‐mold fermentation product raw material.

Classes IPC  ?

• C12N 1/10 - ProtozoairesLeurs milieux de culture
• A23L 7/104 - Fermentation de céréales farineuses ou de produits de céréalesAdjonction d'enzymes ou de micro-organismes
• A23L 7/25 - Fermentation de malt de céréales ou de céréales par maltage
• A23L 11/20 - Produits à base de malt; Produits à base de malt fermenté
• A61K 8/9728 - Champignons, p. ex. levures
• A61K 8/99 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de micro-organismes autres que des algues ou des champignons, p. ex. à base de protozoaires ou de bactéries
• C12N 1/14 - ChampignonsLeurs milieux de culture

Abrégé

Provided are a non-REM sleep promoter and a food composition for promoting non-REM sleep. The non-REM sleep promoter and the food composition for promoting non-REM sleep contain a euglena-derived material as an active ingredient, and promote non-REM sleep.

Classes IPC  ?

• A61K 35/68 - Protozoaires, p. ex. flagelles, amibes, sporozoaires, plasmodium ou toxoplasma
• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61P 25/20 - HypnotiquesSédatifs

Abrégé

Provided are a food composition for improving an intestinal flora balance and an intestinal flora balance improving agent, each of which contains a euglena-derived substance as an active ingredient. The present invention can be solved by a food composition for improving an intestinal flora balance and an intestinal flora balance improving agent, each of which contains a euglena-derived substance as an active ingredient and can be used for decreasing a ratio determined by dividing an occupancy of a bacterium classified into the phylum Firmicutes in an intestinal flora by an occupancy of a bacterium classified into the phylum Bacteroidetes in the intestinal flora (i.e., a F/B ratio).

Classes IPC  ?

• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61K 31/716 - Glucanes
• A61K 35/68 - Protozoaires, p. ex. flagelles, amibes, sporozoaires, plasmodium ou toxoplasma
• A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
• A61P 3/04 - AnorexigènesMédicaments de l'obésité
• A61P 3/06 - Antihyperlipémiants
• A61P 3/10 - Médicaments pour le traitement des troubles du métabolisme de l'homéostase du glucose de l'hyperglycémie, p. ex. antidiabétiques
• A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire

Abrégé

As novel use of an Euglena extract, provided are: a novel adipocyte differentiation inhibitor; a PPARγ expression inhibitor; a C/EBPα expression inhibitor; a food composition for inhibiting adipocyte differentiation; and a cosmetic composition for inhibiting adipocyte differentiation. The novel adipocyte differentiation inhibitor, PPARγ expression inhibitor, C/EBPα expression inhibitor, food composition for inhibiting adipocyte differentiation and cosmetic composition for inhibiting adipocyte differentiation each comprise an aqueous solvent extract of Euglena as an active ingredient. The aqueous solvent extract of Euglena may be, for example, a water extract or hot water extract of Euglena.

Classes IPC  ?

• A61K 35/68 - Protozoaires, p. ex. flagelles, amibes, sporozoaires, plasmodium ou toxoplasma
• A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
• A61K 8/9706 - Algues
• A61P 3/04 - AnorexigènesMédicaments de l'obésité
• A61P 3/06 - Antihyperlipémiants
• A61P 3/10 - Médicaments pour le traitement des troubles du métabolisme de l'homéostase du glucose de l'hyperglycémie, p. ex. antidiabétiques
• A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale
• A61P 9/12 - Antihypertenseurs
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
• A61Q 1/00 - Préparations pour le maquillagePoudres corporellesPréparations pour le démaquillage
• A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
• A61Q 19/00 - Préparations pour les soins de la peau

Abrégé

[Problem] To provide: a hydrocarbon production method with which it is possible to efficiently manufacture a hydrocarbon by using biomass, thus suppressing a carbon resource loss; a production apparatus therefor; a production system therefor; and a biocrude production method. [Solution] The present invention is characterized by being provided with: a pre-processing step for obtaining a biocrude by performing solvolysis by mixing at least a biomass and a solvent; and a fluid catalytic cracking step for performing fluid catalytic cracking by using the biocrude obtained in the pre-processing step and a hydrogen donor as raw materials.

Classes IPC  ?

• C10G 1/00 - Production de mélanges liquides d'hydrocarbures à partir de schiste bitumineux, de sable pétrolifère ou de matières carbonées solides non fusibles ou similaires, p. ex. bois, charbon
• C10G 3/00 - Production de mélanges liquides d'hydrocarbures à partir de matières organiques contenant de l'oxygène, p. ex. huiles, acides gras
• C10G 47/30 - Craquage des huiles d'hydrocarbures, en présence d'hydrogène ou de composés donneurs d'hydrogène, pour obtenir des fractions à point d'ébullition inférieur avec des particules solides en mouvement selon la technique du "lit fluidisé"

Abrégé

Provided are a novel non-alcoholic fatty liver disease therapeutic or prophylactic agent and non-alcoholic fatty liver disease prophylactic food. The present invention is a non-alcoholic fatty liver disease therapeutic or prophylactic agent containing a green-algae-derived substance as an active ingredient. The green-algae-derived substance is chlorella. The present invention is used as a non-alcoholic fatty steatohepatitis therapeutic or prophylactic agent. The present invention is used as a liver fibrosis inhibitor. In addition, the present invention is a non-alcoholic fatty liver disease prophylactic food containing the green-algae-derived substance as an active ingredient.

Classes IPC  ?

• A61K 36/05 - Chlorophycota ou chlorophyta (algues vertes), p. ex. Chlorella
• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques

Abrégé

Euglena-derived material as an active ingredient.

Classes IPC  ?

• A61K 35/68 - Protozoaires, p. ex. flagelles, amibes, sporozoaires, plasmodium ou toxoplasma
• A61K 31/716 - Glucanes

Abrégé

Provided are an antiviral agent and an antiviral food that are novel ways to use an extract from a wild watermelon. The antiviral agent and the antiviral food each contain, as an active ingredient, an extract from a wild watermelon, and are used for prevention or treatment of an infectious disease caused by a virus. For example, the virus is an RNA virus, and is selected from the group consisting of influenza viruses, rotaviruses, and noroviruses. Further, for example, the extract of a wild watermelon is a fruit juice (extract) obtained from the fruit of a wild watermelon.

Classes IPC  ?

• A61K 36/42 - Cucurbitaceae (famille du concombre)
• A61P 31/12 - Antiviraux
• A61P 31/14 - Antiviraux pour le traitement des virus ARN

Abrégé

Provided are an antiviral agent and an antiviral food as novel methods for utilizing a euglena-derived substance. The antiviral agent and antiviral food, both comprising a euglena-derived substance as an active ingredient, are to be used for preventing or treating an infectious disease caused by an envelope-free RNA virus. Examples of the envelope-free RNA virus include rotaviruses belonging to Reoviridae. Examples of the euglena-derived substance include euglena, a hot water extract of euglena, paramylon and an alkali-treated paramylon.

Classes IPC  ?

• A61K 35/68 - Protozoaires, p. ex. flagelles, amibes, sporozoaires, plasmodium ou toxoplasma
• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61K 31/716 - Glucanes
• A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
• A61P 31/14 - Antiviraux pour le traitement des virus ARN

Abrégé

Euglena or a processed product thereof as an active ingredient. In the case of the renal failure progression inhibitor, for example, paramylon is continuously orally administered to a patient suffering from chronic renal failure, undergoing a dialysis therapy, several times per day in a dose of 1 to 5 g per intake. In particular, the renal failure progression inhibitor is singly administered to the patient in a capsule or powdered preparation at a prescribed time interval before and after administration of other drugs.

Classes IPC  ?

• A61K 31/716 - Glucanes

Abrégé

Provided are a novel methanation inhibitor having Euglena as an active ingredient, a ruminant feed, and a method for inhibiting methanation. A methanation inhibitor including Euglena as an active ingredient. A methanation inhibitor including Euglena as an active ingredient, for administration to a ruminant. A ruminant feed including a methanation inhibitor including Euglena as an active ingredient, usable also as a digestibility improver for improving digestibility of the feed in the lumen of a ruminant.

Classes IPC  ?

• A23K 50/10 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les ruminants
• A23K 10/16 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires

Abrégé

　The present invention provides a method for producing organic acid using algal biomass. The present invention pertains to the production of organic acids such as succinic acid using Euglena, by means of a method containing: either a nitrogen deficient culture step in which Euglena is cultured aerobically under nitrogen-deficient conditions or a heterophic culture step in which Euglena is cultured aerobically using a culture medium containing a carbon source; and an anaerobic culture step in which the culture product obtained in the nitrogen-deficient culture step is incubated under anaerobic conditions.

Classes IPC  ?

• C12P 7/46 - Acides dicarboxyliques ayant au plus quatre atomes de carbone, p. ex. acide fumarique, acide maléique
• C12N 1/10 - ProtozoairesLeurs milieux de culture
• C12N 1/12 - Algues unicellulairesLeurs milieux de culture
• C12P 7/40 - Préparation de composés organiques contenant de l'oxygène contenant un groupe carboxyle

Abrégé

Provided are a suppressive agent, a prophylactic agent and a therapeutic agent for rheumatoid arthritis, each of which has little adverse side effects and can normalize immune abnormality in rheumatoid arthritis. A suppressing agent, a prophylactic agent or a therapeutic agent for rheumatoid arthritis, which contains a euglena-derived substance as an active ingredient. The agent can remedy immune abnormality in rheumatoid arthritis, and therefore can be used as an antirheumatic drug capable of controlling the activity of rheumatoid arthritis. The agent can also be used for a living body which does not receive a definitive diagnosis for rheumatoid arthritis yet. The agent is administered to the living body continuously for a period before the definitive diagnosis for rheumatoid arthritis till an arbitrary time point elapsed after the definitive diagnosis. The euglena-derived substance is at least one substance selected from the group consisting of an alga body of euglena, paramylon which is originated from the euglena, water-soluble amorphous paramylon which is produced by subjecting the aforementioned paramylon to an alkali treatment and a neutralization treatment, and emulsion paramylon which is produced by subjecting the aqueous paramylon solution to such a treatment that the aqueous solution is ejected through a microhole nozzle under a super-high pressure to bombard the aqueous solution against an object to be bombarded.

Classes IPC  ?

• A61K 35/68 - Protozoaires, p. ex. flagelles, amibes, sporozoaires, plasmodium ou toxoplasma
• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61K 31/716 - Glucanes
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]

Abrégé

Provided are a prophylactic or therapeutic agent for peptic ulcer, said agent exerting little side effects, a food additive for prophylactic or therapeutic use, an iNOS expression inhibitor and a COX-2 expression inhibitor. The prophylactic or therapeutic agent for peptic ulcer comprises a euglena-derived substance as an active ingredient. The euglena-derived substance is euglena, paramylon or an acid treatment product of paramylon obtained by treating paramylon with an acid. The agent is usable for preventing or treating peptic ulcer caused by psychogenic stress. The peptic ulcer is gastric ulcer. The food additive for preventing or treating peptic ulcer comprises a euglena-derived substance as an active ingredient.

Classes IPC  ?

• A61K 35/68 - Protozoaires, p. ex. flagelles, amibes, sporozoaires, plasmodium ou toxoplasma
• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A61K 31/716 - Glucanes
• A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse

Abrégé

Euglena gracilis strain EOD-1 (Accession No. FERM BP-11530) or its mutant strain and that are capable of producing at least polysaccharides to produce at least one organic compound selected from the group consisting of polysaccharides, lipids, vitamin C, vitamin E, pigments, and proteins.

Classes IPC  ?

• C12P 19/04 - Polysaccharides, c.-à-d. composés contenant plus de cinq radicaux saccharide reliés entre eux par des liaisons glucosidiques
• C12N 1/12 - Algues unicellulairesLeurs milieux de culture
• C12R 1/89 - Algues
• C12P 1/00 - Préparation de composés ou de compositions, non prévue dans les groupes , utilisant des micro-organismes ou des enzymesProcédés généraux de préparation de composés ou de compositions utilisant des micro-organismes ou des enzymes
• C12P 7/64 - GraissesHuilesCires de type esterAcides gras supérieurs, c.-à-d. ayant une chaîne continue d'au moins sept atomes de carbone liée à un groupe carboxyleHuiles ou graisses oxydées

Abrégé

Provided are a novel renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor, which are intended for human use, in particular, for renal insufficiency patients. A renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor each comprising paramylon from Euglena or a processed product thereof as an active ingredient. In the case of the renal insufficiency progression inhibitor, for example, 1-5 g per dose of paramylon is orally administered to a chronic renal insufficiency patient in dialysis treatment several times per day continuously. In particular, the renal insufficiency progression inhibitor is administered alone to the patient in the form of a capsule or dust at some preset time interval before or after administering other drug(s).

Classes IPC  ?

• A61K 31/716 - Glucanes
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
• A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
• A61P 13/12 - Médicaments pour le traitement des troubles du système urinaire des reins
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Abrégé

Provided are: an algae cultivation method whereby an osmotic pressure regulator can be efficiently produced using simple steps; a production method for said regulator; and an algae cultivation method that recovers carbon dioxide from a mixed gas including carbon dioxide and sulfurous acid gas. The algae cultivation method includes: a step in which, under a plurality of cultivation conditions having different temperature, pH, and salt concentration conditions, environmental sample-derived microalgae cultures are cultivated under photoautotrophic conditions and a plurality of enriched cultures that contain at least 1 wt% betaine, etc., and have different dominant species of microalgae plexus are prepared; a step in which an optimum enriched culture suitable for main cultivation is selected from the plurality of enriched cultures in accordance with the expected culture medium temperature and pH fluctuation for the main cultivation and a culturing plan for the main cultivation operation is prepared; a step in which the optimum enriched culture is used, main cultivation occurs under photoautotrophic conditions and at a salt concentration of at least 10 wt%, and a betaine-containing main culture is prepared; and a betaine-separation step. During main cultivation, a mixed gas including sulfurous acid gas and carbon dioxide is blown into a betaine-containing algae culture solution and algae is cultivated.

Classes IPC  ?

• C12N 1/12 - Algues unicellulairesLeurs milieux de culture
• B01D 53/50 - Oxydes de soufre
• B01D 53/52 - Sulfure d'hydrogène
• B01D 53/62 - Oxydes de carbone
• C12P 13/00 - Préparation de composés organiques contenant de l'azote
• C12P 19/02 - Monosaccharides

Abrégé

Provided is a novel immune balance adjustment agent for adjusting the immune balance of an organism. This immune balance adjustment agent is one which: contains a euglena-derived substance; and adjusts the Th1/Th2/Th17 immune balance, which is the balance of immune responses derived from Th1, Th2 and Th17 in the organism. The immune balance adjustment agent is used to improve physical constitutions in which the Th1/Th2/Th17 immune balance leans toward Th2, and in the prevention or treatment of diseases to which a lean toward Th2 in the Th1/Th2/Th17 immune balance contributes, by adjusting the Th1/Th2/Th17 immune balance in a manner such that the immune response derived from Th1 is adjusted in a relatively superior direction relative to the immune responses derived from Th2 or Th17. This agent is to be administered prior to the period during which the onset of a disease to which a lean toward Th2 in the Th1/Th2/Th17 immune balance contributes is predicted.

Classes IPC  ?

• A61K 36/05 - Chlorophycota ou chlorophyta (algues vertes), p. ex. Chlorella
• A23L 1/30 - contenant des additifs (A23L 1/308 a priorité);;
• A61K 31/716 - Glucanes
• A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
• A61P 31/00 - Agents anti-infectieux, c.-à-d. antibiotiques, antiseptiques, chimiothérapeutiques
• A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus
• A61P 37/02 - Immunomodulateurs
• A61P 37/08 - Agents antiallergiques
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
• C12N 1/10 - ProtozoairesLeurs milieux de culture

Abrégé

Provided is a β-1,3-glucanase that exhibits decomposition activity with respect to Euglena genus-derived paramylon. The β-1,3-glucanase is derived from the Euglena genus and exhibits the properties indicated below. (1) Effect: hydrolyzes the β-1,3- bond of β-1,3-glucan. (2) Substrate specificity: decomposes at least paramylon. The β-1,3-glucanase additionally exhibits the properties indicated below. (3) Decomposition activity: the ratio of paramylon decomposition activity with respect to laminarin decomposition activity is 20% or higher. (4) Optimum pH: 3.7-7.0. (5) Optimum temperature: 30-70 °C.

Classes IPC  ?

• C12N 15/09 - Technologie d'ADN recombinant
• C12N 1/15 - ChampignonsLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
• C12N 1/19 - LevuresLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
• C12N 1/21 - BactériesLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
• C12N 5/10 - Cellules modifiées par l'introduction de matériel génétique étranger, p. ex. cellules transformées par des virus
• C12N 9/24 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2)
• C12P 19/14 - Préparation de composés contenant des radicaux saccharide préparés par action d'une carbohydrase, p. ex. par action de l'alpha-amylase

Abrégé

　Provided are a method for introducing a gene to Euglena, which can stably maintain a foreign gene, and a transformant therefrom.　In this method for introducing a gene to Euglena, a DNA fragment containing an amino acid sequence for coding a protein is introduced into a Euglena cell. The method comprises: a step for producing a binary vector containing a DNA fragment; a step for obtaining a linear gene fragment comprising a T-DNA region including the DNA fragment in the binary vector; and a direct gene introduction step for directly introducing the linear gene fragment into the Euglena cell.

Classes IPC  ?

• C12N 15/09 - Technologie d'ADN recombinant
• C12N 1/13 - Algues unicellulairesLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
• C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)

Abrégé

Provided is a euglena in which an objective exogeneous gene is held in an expressible state. The euglena has a chemical-resistant gene and an objective exogeneous gene which are held therein in an expressible state.

Classes IPC  ?

• C12N 1/13 - Algues unicellulairesLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
• C12N 15/09 - Technologie d'ADN recombinant
• C12R 1/89 - Algues

Abrégé

Provided is a method that is for producing Euglena having a high wax ester content and that is able to more effectively produce Euglena having a high wax ester content by restoring the fermentation efficiency of wax esters by adding a nutrient before anaerobic fermentation. The main configuration of the method is that there is at least a first step for aerobically cultivating the microalga Euglena in nitrogen-poor conditions, and a second step for holding the cells in an anaerobic state, and before the second step, a nutrient source is added to the culture liquid that has passed through the first step.

Classes IPC  ?

• C12N 1/12 - Algues unicellulairesLeurs milieux de culture
• C12N 1/10 - ProtozoairesLeurs milieux de culture
• C12P 7/64 - GraissesHuilesCires de type esterAcides gras supérieurs, c.-à-d. ayant une chaîne continue d'au moins sept atomes de carbone liée à un groupe carboxyleHuiles ou graisses oxydées

Abrégé

A method for producing a fuel oil base, provided with: a first step for aerobically culturing microalgae Euglena under nitrogen-deficient conditions; a second step for adding a nutrient source to a solution to be treated, the solution containing the microalgae Euglena cultured in the first step, and then setting the dissolved oxygen concentration of the solution to be treated at 0.03 mg/L or lower, conducting anaerobic fermentation of the microalgae Euglena, and obtaining a wax ester; and a third step for hydrogenating stock oil containing the wax ester and obtaining a fuel oil base.

Classes IPC  ?

• C12P 7/64 - GraissesHuilesCires de type esterAcides gras supérieurs, c.-à-d. ayant une chaîne continue d'au moins sept atomes de carbone liée à un groupe carboxyleHuiles ou graisses oxydées
• C10G 3/00 - Production de mélanges liquides d'hydrocarbures à partir de matières organiques contenant de l'oxygène, p. ex. huiles, acides gras
• C10L 1/04 - Combustibles carbonés liquides à base essentielle de mélanges d'hydrocarbures

Abrégé

euglena highly containing a wax ester can be produced; and a method for producing a wax ester. euglena, a second step of further culturing a medium under nitrogen-starvation conditions, and a third step of retaining the cells under anaerobic conditions.

Classes IPC  ?

• C12P 7/64 - GraissesHuilesCires de type esterAcides gras supérieurs, c.-à-d. ayant une chaîne continue d'au moins sept atomes de carbone liée à un groupe carboxyleHuiles ou graisses oxydées
• C12N 1/12 - Algues unicellulairesLeurs milieux de culture
• C12N 15/82 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules végétales

Abrégé

The present invention provides a production method for biofuel based on a technology to convert carbon-dioxide as a carbon source through photosynthesis by photosynthetic microorganisms to biomass and produce biofuel of the biomass. The production method for biofuel of the present invention comprises a culturing process (S1) of culturing in a culture solution photosynthetic microorganisms which store oils, fats and carbohydrates in cells of the photosynthetic microorganisms, an oil and fat conversion process (S2) of converting the carbohydrates stored in the cells of the photosynthetic microorganisms cultured in the culture apparatus to oils and fats, an extraction process (S3) of extracting the oils and fats out of the cells of the photosynthetic microorganisms, and a reforming process (S4) to reform the extracted oils and fats.

Classes IPC  ?

• C12N 1/00 - Micro-organismes, p. ex. protozoairesCompositions les contenantProcédés de culture ou de conservation de micro-organismes, ou de compositions les contenantProcédés de préparation ou d'isolement d'une composition contenant un micro-organismeLeurs milieux de culture
• C12N 1/12 - Algues unicellulairesLeurs milieux de culture
• C12P 7/64 - GraissesHuilesCires de type esterAcides gras supérieurs, c.-à-d. ayant une chaîne continue d'au moins sept atomes de carbone liée à un groupe carboxyleHuiles ou graisses oxydées
• C10L 1/02 - Combustibles carbonés liquides à base essentielle de composants formés uniquement de carbone, d'hydrogène et d'oxygène

Abrégé

The present invention provides an allergy inhibitor using the efficacy of amorphous paramylon which is a substance obtained by changing the crystalline structure of paramylon. The present invention relates to a substance for inhibiting allergic diseases. Amorphous paramylon of the present invention is an allergy inhibitor comprising amorphous paramylon which is obtained by amorphosizing crystalline paramylon derived from Euglena, and has a relative crystallinity of 20% or lower to the crystallinity of crystalline paramylon, determined by an X-ray diffractometry. This allergy inhibitor enables efficacious inhibition of allergic diseases such as atopic dermatitis, pollinosis, and the like.

Classes IPC  ?

• A61K 31/716 - Glucanes
• A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
• C08B 37/00 - Préparation des polysaccharides non prévus dans les groupes Leurs dérivés
• A61P 37/08 - Agents antiallergiques

Abrégé

[Problem] To provide: a process for producing euglena containing a wax ester at a high content, by culturing a microalga euglena aerobically by photosynthesis using carbon dioxide as a carbon source, further culturing the microalga euglena under nitrogen-starved conditions to increase the amount of accumulated paramylon per cell, and subsequently leaving the microalga euglena under anaerobic conditions, thereby producing euglena containing a wax ester at a high content; and a process for producing a wax ester. [Solution] The invention relates to a process for producing euglena containing a wax ester at a high content. The process comprises a first step of culturing a microalga euglena aerobically, a second step of further culturing the microalga euglena while retaining the culture medium under nitrogen-starved conditions, and a third step of retaining cells of the microalga euglena under anaerobic conditions.

Classes IPC  ?

• C12N 1/12 - Algues unicellulairesLeurs milieux de culture
• C12P 7/64 - GraissesHuilesCires de type esterAcides gras supérieurs, c.-à-d. ayant une chaîne continue d'au moins sept atomes de carbone liée à un groupe carboxyleHuiles ou graisses oxydées

Abrégé

Disclosed are a series of processes for producing a biofuel, which include a technique wherein carbon dioxide serving as a carbon source is converted into a biomass by photosynthesis by photosynthetic microorganisms and the production of a biofuel is carried out after that. Specifically disclosed is a method for producing a biofuel, which is characterized by comprising: a culture step (S1) wherein photosynthetic microorganisms that accumulate a fat or oil and a carbohydrate in the cells thereof are cultured in a broth; a fat or oil conversion step (S2) wherein the carbohydrate accumulated in the cells of the photosynthetic microorganisms, which have been cultured in the broth, is converted into a fat or oil; an extraction step (S3) wherein the oil or fat is extracted from the cells of the photosynthetic microorganisms; and a modification step (S4) wherein the extracted fat or oil is modified.

Classes IPC  ?

• C12P 1/00 - Préparation de composés ou de compositions, non prévue dans les groupes , utilisant des micro-organismes ou des enzymesProcédés généraux de préparation de composés ou de compositions utilisant des micro-organismes ou des enzymes
• C10G 3/00 - Production de mélanges liquides d'hydrocarbures à partir de matières organiques contenant de l'oxygène, p. ex. huiles, acides gras
• C10L 1/00 - Combustibles carbonés liquides
• C12P 7/64 - GraissesHuilesCires de type esterAcides gras supérieurs, c.-à-d. ayant une chaîne continue d'au moins sept atomes de carbone liée à un groupe carboxyleHuiles ou graisses oxydées

Abrégé

Disclosed is an allergy inhibitor using the efficacy of amorphous paramylon which is a substance obtained by changing the crystalline structure of paramylon. A substance for inhibiting allergic diseases. The aforesaid allergy inhibitor comprises amorphous paramylon which is obtained by amorphousizing euglena-origin crystalline paramylon and has a relative crystallinity, to the crystallinity of crystalline paramylon, determined by X-ray diffractometry of 20% or lower. This allergy inhibitor can efficaciously inhibit allergic diseases such as atopic dermatitis, pollinosis and so on.

Classes IPC  ?

• C08B 37/00 - Préparation des polysaccharides non prévus dans les groupes Leurs dérivés
• A61K 31/716 - Glucanes
• A61P 11/02 - Agents rhinologiques, p. ex. décongestionnants
• A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
• A61P 37/08 - Agents antiallergiques